Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.

Disease Models & Mechanisms
Joe W McGreevyDongsheng Duan

Abstract

Duchenne muscular dystrophy (DMD) is a progressive muscle-wasting disorder. It is caused by loss-of-function mutations in the dystrophin gene. Currently, there is no cure. A highly promising therapeutic strategy is to replace or repair the defective dystrophin gene by gene therapy. Numerous animal models of DMD have been developed over the last 30 years, ranging from invertebrate to large mammalian models. mdx mice are the most commonly employed models in DMD research and have been used to lay the groundwork for DMD gene therapy. After ~30 years of development, the field has reached the stage at which the results in mdx mice can be validated and scaled-up in symptomatic large animals. The canine DMD (cDMD) model will be excellent for these studies. In this article, we review the animal models for DMD, the pros and cons of each model system, and the history and progress of preclinical DMD gene therapy research in the animal models. We also discuss the current and emerging challenges in this field and ways to address these challenges using animal models, in particular cDMD dogs.

References

Feb 1, 1992·American Journal of Medical Genetics·B A ValentineB J Cooper
Jan 1, 1991·Neuromuscular Disorders : NMD·F MuntoniG Serra
Mar 1, 1991·Journal of the American College of Cardiology·N S MoiseR F Gilmour
Jan 1, 1991·Neuromuscular Disorders : NMD·B A Valentine, B J Cooper
May 1, 1990·Journal of Veterinary Internal Medicine·B A ValentineB J Cooper
Jun 1, 1990·Journal of the Neurological Sciences·B A ValentineA de Lahunta
Apr 1, 1989·Journal of Comparative Pathology·B A ValentineE A Gallagher
Jan 1, 1989·Neuron·E P Hoffman, L M Kunkel
Oct 1, 1989·Annals of Neurology·B A ValentineB J Cooper
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·V M ChapmanC T Caskey
Oct 1, 1988·Muscle & Nerve·J N KornegayD C Levesque
Nov 1, 1988·The Journal of Heredity·B J CooperP W Concannon
Dec 1, 1988·Journal of the Neurological Sciences·B A ValentineJ T Blue
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G BulfieldK J Moore
Apr 12, 1980·The Veterinary Record·B FunkquistL Stahre
Aug 1, 1995·Human Molecular Genetics·S F PhelpsJ S Chamberlain
May 1, 1995·The Anatomical Record·J P LefaucheurA Sebille
Apr 1, 1995·Journal of the Neurological Sciences·C Pastoret, A Sebille
Sep 1, 1994·Neuromuscular Disorders : NMD·N J WinandB J Cooper
Apr 1, 1993·Nature Genetics·A H Ahn, L M Kunkel
May 1, 1993·Archives of Disease in Childhood·L V NicholsonD Gardner-Medwin
Jun 1, 1993·Human Molecular Genetics·M G DunckleyG Dickson
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·S KochanekC T Caskey
May 15, 1996·Genes & Development·L A MegeneyM A Rudnicki

❮ Previous
Next ❯

Citations

Jun 25, 2016·Expert Opinion on Orphan Drugs·Yongping YueDongsheng Duan
Jan 15, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Versha PrakashRafael J Yáñez-Muñoz
Feb 13, 2016·Frontiers in Immunology·Zhiwei Ang, Jeak Ling Ding
Jan 1, 2016·Journal of Cardiovascular Translational Research·Dongsheng DuanKathi Kinnett
Jan 1, 2015·Journal of Neuromuscular Diseases·Chady H HakimDongsheng Duan
Oct 9, 2015·Science Translational Medicine·Amir KolDori L Borjesson
Apr 6, 2016·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Thais Borges LessaCarlos Eduardo Ambrósio
Aug 8, 2015·Current Pathobiology Reports·Elizabeth W Uhl, Natalie J Warner
May 25, 2016·Genome Medicine·Ignazio MaggioManuel A F V Gonçalves
May 26, 2016·Development, Growth & Differentiation·Hiroshi Yajima, Kiyoshi Kawakami
Apr 14, 2016·Stem Cells·Andrew M Hoffman, Steven W Dow
Jun 7, 2015·Annual Review of Genomics and Human Genetics·Simon GuiraudLouis M Kunkel
Apr 6, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·S L Eaton, T M Wishart
Apr 12, 2017·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Michael E NanceDongsheng Duan
May 10, 2017·Nature Reviews. Genetics·Alessandra BreschiRoderic Guigó
Apr 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Valentina SardoneMaria Sofia Falzarano
Oct 30, 2015·Toxicologic Pathology·Nikolai KlymiukEckhard Wolf
Apr 20, 2017·Chembiochem : a European Journal of Chemical Biology·Jonathan Okerblom, Ajit Varki
Jun 19, 2017·Respiratory Physiology & Neurobiology·Gabriela de Cássia Sousa AmancioOlivier Cazorla
Jan 8, 2016·Dose-response : a Publication of International Hormesis Society·Volkan GurelJohn McMichael
Jul 26, 2017·Nature Communications·Caroline Le GuinerGeorge Dickson
Jan 26, 2018·Journal of Cardiovascular Development and Disease·Jennifer EnglandCatrin Sian Rutland
Oct 17, 2017·Journal of Personalized Medicine·Quynh Nguyen, Toshifumi Yokota
Sep 11, 2017·American Journal of Medical Genetics. Part a·James J DowlingCraig Campbell
May 3, 2018·Physiological Reviews·Yu ZhangEric N Olson
Feb 9, 2018·Disease Models & Mechanisms·Carolin PerlebergAngelika Schnieke
Apr 20, 2018·Antioxidants & Redox Signaling·Katarzyna Pietraszek-GremplewiczJozef Dulak
Sep 7, 2017·Muscle & Nerve·Rylie M Hightower, Matthew S Alexander
May 10, 2018·Muscle & Nerve·Giorgia Catarinella, Lucia Latella

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide
gene-knockout
transgenic

Software Mentioned

Lifespan

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Reinhardt Rüdel
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
© 2022 Meta ULC. All rights reserved